---
title: "Cibus Stockholders Approve Directors and Governance Measures"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288870166.md"
description: "Cibus, Inc. held its 2026 Annual Meeting of Stockholders on June 2, electing nine directors, approving executive compensation, and ratifying BDO USA as independent auditor. The meeting reaffirmed the company's governance structure. While analysts maintain a 'Buy' rating with a $25 price target, TipRanks’ AI Analyst Spark rates CBUS as Neutral due to unprofitability and cash burn, despite positive cost reduction signals."
datetime: "2026-06-05T13:21:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288870166.md)
  - [en](https://longbridge.com/en/news/288870166.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288870166.md)
---

# Cibus Stockholders Approve Directors and Governance Measures

The latest announcement is out from Cibus ( (CBUS) ).

Cibus, Inc. held its 2026 Annual Meeting of Stockholders on June 2, 2026, with approximately 69.52% of its 76,345,736 Class A shares present, establishing a quorum and underscoring solid shareholder participation. At the meeting, nine directors, including Mark Finn and Rory Riggs, were elected to one-year terms, executive compensation received advisory approval, and BDO USA, P.C. was ratified as the company’s independent auditor for the 2026 fiscal year, decisions that collectively reaffirm the existing governance structure and financial oversight framework for stakeholders.

The most recent analyst rating on (CBUS) stock is a Buy  
with a $25.00 price target.  
To see the full list of analyst forecasts on Cibus stock,  
see the CBUS Stock Forecast page.

**Spark’s Take on CBUS Stock**

According to Spark, TipRanks’ AI Analyst, CBUS is a Neutral.

The score is held back mainly by deep unprofitability and sustained cash burn, alongside weak technical trends. These are partially offset by constructive earnings-call signals—significant cost reductions, extended cash runway after recent financing, and continued commercial/regulatory progress—though the outlook remains highly execution-dependent.

To see Spark’s full report on CBUS stock,  
click here.

**More about Cibus**

Cibus, Inc. operates in the agricultural biotechnology sector, focusing on developing and commercializing plant traits and crop technologies for the global food and agriculture markets. The company’s work centers on improving crop performance and resilience, positioning it within the broader ag-tech and seed innovation landscape.

**Average Trading Volume:** 526,546

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $106.1M

See more data about CBUS stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [CBUS.US](https://longbridge.com/en/quote/CBUS.US.md)

## Related News & Research

- [Meet the Gen Z AI whiz at the center of a hedge fund meltdown](https://longbridge.com/en/news/294425537.md)
- [Theriva Biologics holds annual shareholder meeting](https://longbridge.com/en/news/294814448.md)
- [Zucchi auditor switch delays 2024 accounts approval after BDO resignation](https://longbridge.com/en/news/294545364.md)
- [How the 'Nostradamus of AI' failed to spot a market crash](https://longbridge.com/en/news/294580418.md)
- [Is Corteva (CTVA) A Bargain Following Its 2026 Guidance Raise?](https://longbridge.com/en/news/294604867.md)